These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17413929)

  • 1. Thrombosis after hypothermic circulatory arrest for cardiovascular surgery, antifibrinolytic drugs, and thrombophilia.
    Casati V; Zanetti PP; D'Angelo A
    Anesthesiology; 2007 Apr; 106(4):874; author reply 874-5. PubMed ID: 17413929
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular thrombosis associated with aprotinin and deep hypothermic circulatory arrest: where are we in 2006?
    Augoustides JG
    Anesthesiology; 2007 Apr; 106(4):873; author reply 874-5. PubMed ID: 17413927
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of severe diffuse venous thromboembolism associated with aprotinin and hypothermic circulatory arrest in a cardiac surgical patient with factor V Leiden.
    Shore-Lesserson L; Reich DL
    Anesthesiology; 2006 Jul; 105(1):219-21. PubMed ID: 16810016
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracardiac thrombosis and acute right ventricular failure following complex reoperative cardiac surgery with aprotinin and deep hypothermic circulatory arrest.
    Stone ME; Silverman SH; Nomoto K
    Semin Cardiothorac Vasc Anesth; 2007 Sep; 11(3):177-84. PubMed ID: 17711970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis after deep hypothermic circulatory arrest with antifibrinolytic therapy: is factor V leiden the smoking gun?
    Donahue BS
    Anesthesiology; 2002 Sep; 97(3):760-1; author reply 761. PubMed ID: 12218560
    [No Abstract]   [Full Text] [Related]  

  • 6. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
    Martin K; Wiesner G; Breuer T; Lange R; Tassani P
    Anesth Analg; 2008 Dec; 107(6):1783-90. PubMed ID: 19020118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro: aprotinin should be used in patients undergoing hypothermic circulatory arrest.
    Royston D
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):121-5. PubMed ID: 11254854
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated?
    Ramsay MA; Randall HB; Burton EC
    Liver Transpl; 2004 Feb; 10(2):310-4. PubMed ID: 14762872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin revisited.
    Deanda A; Spiess BD
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):998-1002. PubMed ID: 22795461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal thrombosis in complex cardiac surgery without deep hypothermic circulatory arrest in the setting of standard-of-care heparinization: Status quo and directions for further research.
    Augoustides JG
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1053-4. PubMed ID: 17903533
    [No Abstract]   [Full Text] [Related]  

  • 11. Lessons learned in antifibrinolytic therapy: The BART trial.
    Murkin JM
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):127-31. PubMed ID: 19622534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jugular bulb oxygen saturation in hypothermic circulatory arrest procedures: a possible role of continuous monitoring.
    Paino R; Milazzo F
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):172-3. PubMed ID: 18249358
    [No Abstract]   [Full Text] [Related]  

  • 13. Con: aprotinin should not be used in patients undergoing hypothermic circulatory arrest.
    Gravlee GP
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):126-8. PubMed ID: 11254855
    [No Abstract]   [Full Text] [Related]  

  • 14. Judging the safety of aprotinin.
    Mangano DT; Rieves RD; Weiss KD
    N Engl J Med; 2006 Nov; 355(21):2261-2. PubMed ID: 17124031
    [No Abstract]   [Full Text] [Related]  

  • 15. The value of phase 4 clinical testing.
    Vlahakes GJ
    N Engl J Med; 2006 Jan; 354(4):413-5. PubMed ID: 16436775
    [No Abstract]   [Full Text] [Related]  

  • 16. RIFLE criteria for acute kidney injury in aortic arch surgery.
    Arnaoutakis GJ; Bihorac A; Martin TD; Hess PJ; Klodell CT; Ejaz AA; Garvan C; Tribble CG; Beaver TM
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1554-60; discussion 1560-1. PubMed ID: 18023682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 18. Observational studies of drug safety--aprotinin and the absence of transparency.
    Hiatt WR
    N Engl J Med; 2006 Nov; 355(21):2171-3. PubMed ID: 17124013
    [No Abstract]   [Full Text] [Related]  

  • 19. [Impact of different brain protection techniques upon postoperative temporary neurological dysfunction in aortic surgery with the aid of deep hypothermic circulatory arrest].
    Han QQ; Xu ZY; Zhang BR; Xu JB; Han L; He B; Zhao TJ
    Zhonghua Wai Ke Za Zhi; 2007 Mar; 45(6):419-22. PubMed ID: 17537332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.